GgoogleMX first seen 6 h ago, last 5 h ago, peak #1
Bayer hits milestone expanding Kerendia approval in the US
Original: bayer
Bayer has reached a milestone in expanding the approved uses of its drug Kerendia in the United States, according to MarketScreener. The development matters for the German pharmaceutical group's growth strategy, as Kerendia is one of its key new medicines and broader indications could expand its patient market. Interest is showing up in Google searches in Mexico and Brazil.
Why now: A new regulatory milestone for one of Bayer's key drugs is drawing attention from investors and health watchers.
Rank over time, top of the chart is #1. 3 snapshots from 6 h ago to 5 h ago.
Evidence
- Bayer erreicht Meilenstein bei der Ausweitung der Kerendia-Indikation in den USA · MarketScreener Deutschland
Elsewhere
API: https://socialmediatrends-api.osmike.com/v1/trends/1746560